Non profit patient advocacy group aiming to change the standard of care for cancer patients who will be prescribed 5FU or capecitabine to include DPYD testing prior to treatment. Individuals with certain DPYD gene variants cannot properly excrete excess drug for their body which can result in severe toxicity or even death. By testing patients before treatment with 5FU or capecitabine, suffering will be reduced and lives will be saved.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Battle Creek, Mi 49015, Us
- Industry
- Non-Profit Organizations
- Website
- http://www.test4dpd.org
- Keywords
- NeoDx.
- HQ
- Battle Creek, MI
- Competitors
- Precision Medicine, St. Elizabeth Healthcare, OneOme, NeoDx, American Pharmacogenomics Association, OPTIMIZED INDEPENDENCE OT PLLC, American Society of Clinical Oncology (ASCO), American Association for Cancer Research, National Comprehensive Cancer Network® (NCCN®), Cascading Climate and Health Risks in African Cities (CASCADE).
Advocates For Universal Dpd/dpyd Testing Questions
Advocates For Universal Dpd/Dpyd Testing's website is http://www.test4dpd.org
Advocates For Universal Dpd/Dpyd Testing's LinkedIn profile is https://www.linkedin.com/company/advocates-for-universal-dpd-dpyd-testing
Advocates For Universal Dpd/Dpyd Testing has
2 employees.
View email and phone details for 2
employees at Advocates For Universal Dpd/Dpyd Testing.
Advocates For Universal Dpd/Dpyd Testing's industry is
Non-profit Organizations
Advocates For Universal Dpd/Dpyd Testing's top competitors are
Precision Medicine,
St. Elizabeth Healthcare,
Oneome,
Neodx,
American Pharmacogenomics Association,
Optimized Independence Ot Pllc,
American Society Of Clinical Oncology (Asco),
American Association For Cancer Research,
National Comprehensive Cancer Network® (Nccn®),
Cascading Climate And Health Risks In African Cities (Cascade).
Advocates For Universal Dpd/Dpyd Testing's categories are Non-profit Organizations
Advocates For Universal Dpd/Dpyd Testing's founding year is 2022
